GCG and type 2 diabetes mellitus: Dipeptidyl peptidase 4 (DPP4) is involved in the regulation of incretins GLP-1 and GIP that control blood sugar, and DPP4 inhibitors Sitagliptin, Vildagliptin and Saxagliptin are approved as drugs to treat type 2 diabetes [26]–[28].